- Home
- RMNI vs EYPT Comparison
RMNI vs EYPT Comparison
Compare RMNI & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMNI
- EYPT
- Stock Information
- Founded
- RMNI 2005
- EYPT 1987
- Country
- RMNI United States
- EYPT United States
- Employees
- RMNI N/A
- EYPT N/A
- Industry
- RMNI Business Services
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- RMNI Consumer Discretionary
- EYPT Industrials
- Exchange
- RMNI Nasdaq
- EYPT Nasdaq
- Market Cap
- RMNI 368.8M
- EYPT 390.0M
- IPO Year
- RMNI N/A
- EYPT 2005
- Fundamental
- Price
- RMNI $3.57
- EYPT $5.91
- Analyst Decision
- RMNI Buy
- EYPT Strong Buy
- Analyst Count
- RMNI 2
- EYPT 7
- Target Price
- RMNI $6.00
- EYPT $24.00
- AVG Volume (30 Days)
- RMNI 230.8K
- EYPT 610.5K
- Earning Date
- RMNI 05-01-2025
- EYPT 05-07-2025
- Dividend Yield
- RMNI N/A
- EYPT N/A
- EPS Growth
- RMNI N/A
- EYPT N/A
- EPS
- RMNI N/A
- EYPT N/A
- Revenue
- RMNI $426,212,000.00
- EYPT $56,042,000.00
- Revenue This Year
- RMNI $0.74
- EYPT N/A
- Revenue Next Year
- RMNI $4.46
- EYPT N/A
- P/E Ratio
- RMNI N/A
- EYPT N/A
- Revenue Growth
- RMNI N/A
- EYPT 12.04
- 52 Week Low
- RMNI $1.53
- EYPT $3.91
- 52 Week High
- RMNI $4.15
- EYPT $21.26
- Technical
- Relative Strength Index (RSI)
- RMNI 58.47
- EYPT 45.89
- Support Level
- RMNI $3.22
- EYPT $5.75
- Resistance Level
- RMNI $3.45
- EYPT $6.29
- Average True Range (ATR)
- RMNI 0.21
- EYPT 0.48
- MACD
- RMNI 0.02
- EYPT -0.10
- Stochastic Oscillator
- RMNI 90.38
- EYPT 9.41
About RMNI Rimini Street Inc. (DE)
Rimini Street Inc and its subsidiaries are providers of end-to-end enterprise software support, products, and services. The Company offers a comprehensive family of unified solutions to run, manage, support, customize, configure, connect, protect, monitor, and optimize clients' enterprise applications, database, and technology software platforms. The Company derives revenues from clients by providing subscription support services for enterprise resource planning, customer relationship management, product lifecycle management database, and technology software systems. Geographically, the company generates the majority of its revenue from the United States of America and the International market.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.